ABT1P1

Across TCGA pan-cancer cohorts, ABT1P1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated ABT1P1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher ABT1P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ABT1P1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and STAD show a favorable association.

SKCM, STAD, and OV are the cancer types where ABT1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.834	0.717	.014	54	view →
STAD	OS	Median	III,IV	0.480	0.239	.006	29	view →
OV	OS	Tertile	All	0.776	0.858	.020	18	view →
COAD	DFS	Tertile	IV	0.253	0.513	.012	18	view →
SARC	OS	Tertile	All	0.303	0.618	.001	9	view →
PCPG	DFS	Tertile	All	0.692	0.929	.047	9	view →
KIRC	DFS	Tertile	All	0.935	0.860	.034	6	view →
THYM	DFS	Tertile	III,IV	1.000	0.565	.045	6	view →
BRCA	OS	Tertile	III,IV	0.856	0.514	.039	6	view →
DLBC	OS	Median	IV	1.000	0.527	.033	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

ABT1P1–SKCM (DFS)

Open the SKCM breakdown →